Exploring Altered Free Amino Acids and Metabolites: Insights into the Metabolic Landscape of Preeclampsia

Savas Karakus,Halef Okan Dogan

DOI: https://doi.org/10.1016/j.placenta.2024.06.002

IF: 3.287

2024-06-07

Placenta

Abstract:Introduction Preeclampsia (PE) is a complex disease that poses a risk for maternal and perinatal morbidity and mortality. This study aimed to investigate the role of maternal serum amino acids (AAs) levels in PE. Materials and Methods A total of 56 pregnant women (26 with PE and 30 controls) were included in the study. The participants had a confirmed gestational age between 24 and 37 weeks. The mean body mass index (BMI) for the PE group was 33.0 kg/m 2 , while the control group had a mean BMI of 28.7 kg/m 2 . AAs levels were quantified, and statistical analyses were performed to identify significant differences between the two groups. Receiver Operating Characteristic (ROC) curve analysis was employed the diagnostic potential of specific AAs. Results We observed significantly elevated levels of multiple AAs in the PE group, including citrulline, lysine, ethanolamine, ornithine and histidine. Citrulline exhibited exceptional predictive power for PE with 100.0% sensitivity and specificity at a cutoff of 7.090 μmol/L, reflected in an area under the curve (AUC) of 1.000. Discussion Our study highlights the crucial involvement of altered amino acid levels, specifically in the urea cycle, disruptions in lysine and ethanolamine metabolism in PE development. Exploring these changes may reveal new therapeutic targets, providing insights into the disease's molecular mechanisms. Understanding amino acid metabolism in PE not only informs therapeutic strategies but also holds the potential to revolutionize early diagnosis and intervention.

obstetrics & gynecology,reproductive biology,developmental biology